SCHEDULE: Deep Track Capital Discloses 7.86% Stake in ImageneBio
Beneficial Ownership Disclosure
Deep Track Capital, along with its affiliates, has disclosed a beneficial ownership of 7.86% in ImageneBio, Inc.'s common stock.
Summary
- Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively reported beneficial ownership of 878,516 shares of ImageneBio, Inc. Common Stock.
- This ownership represents 7.86% of ImageneBio, Inc.'s outstanding common stock.
- The calculation of the percentage is based on 11,181,676 common shares outstanding, as reported by ImageneBio, Inc. in an 8-K filing on July 29, 2025.
- The reporting persons share both voting and dispositive power over all 878,516 shares.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, except for activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. It is a neutral regulatory compliance document.
Positives
- A significant institutional investor, Deep Track Capital, has taken a notable stake in ImageneBio, Inc., potentially signaling confidence in the company's prospects.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing indicates an institutional investment firm's significant stake in a biotechnology company, a common occurrence in the sector where specialized funds often take positions in emerging or established biotech firms.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: The disclosure of a new significant institutional shareholder could be viewed positively, potentially indicating increased institutional interest and confidence in ImageneBio, Inc.
Key Dates
| Date | Description |
|---|---|
| 07/28/2025 | Date of event which required the filing of this statement. |
| 07/29/2025 | Date ImageneBio, Inc. filed an 8-K with the SEC, reporting 11,181,676 Common Stock outstanding. |
| 08/04/2025 | Date the Schedule 13G statement was signed by the reporting persons. |
Keywords
ImageneBio, Deep Track Capital, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Biotechnology, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.